Table 4 Choice of NRT medication by product and short-term abstinence rates by type of NRT used; % (n)
Product | All clients (n = 1810) | NRT type | 3–4 week CO-validated abstinence (n = 502) |
|---|---|---|---|
Inhalator | 10.2 (185) | Inhalator | 37.2 (67) |
16 hour patch | 19.4 (352) | Patch | 43.0 (535) |
24 hour patch | 51.7 (936) | ||
2 mg gum | 1.5 (27) | Gum | 35.3 (30) |
4 mg gum | 3.3 (59) | ||
Nasal spray | 2.5 (46) | Nasal spray | 38.6 (17) |
1 mg lozenge1 | .1 (2) | Lozenge | 42.7 (44) |
2 mg lozenge1 | 1.3 (23) | ||
4 mg lozenge1 | 1.4 (25) | ||
Lozenge2 | 3.0 (55) | ||
Microtab | 5.5 (99) | Microtab | 44.3 (43) |